Top Stocks To Buy Today: Bharat Forge, BSE, Glenmark Pharma, Metropolis Healthcare, Tata Chemicals
Analysts chose Bharat Forge Ltd., BSE Ltd., Glenmark Pharmaceuticals Ltd., Metropolis Healthcare Ltd., and Tata Chemicals Ltd. for Wednesday's trading session.
The Street Founder Kunal Rambhia and Angel One Technical and Derivative Research Chief Manager Osho Krishnan shared their views on the above-mentioned stocks.
Bharat Forge
Rambhia recommended a buy for the stock with a target price of Rs 1,300 apiece. The current target price implied a 2.5% upside from Tuesday's close price. The stop loss is at Rs 1,255 apiece.
Out of 29 analysts tracking the company, 13 maintain a 'buy' rating, seven recommend a 'hold', and nine suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies a downside of 9.4%.
BSE
Rambhia recommended a 'Buy' for the stock. The target price is Rs 2,850 apiece, which implied a 3.3% upside from Tuesday's close price. The stop loss is at Rs 2,750.
Out of 14 analysts tracking the company, 10 maintain a 'buy' rating, three recommend a 'hold', and one suggests 'sell', according to Bloomberg data. The average 12-month consensus price target implies a downside of 14.7%.
Glenmark Pharmaceuticals
Krishnan suggested a buy for the stock. The target price for the stock is Rs 1,570, which implies a 3.8% upside from Tuesday's close price. The stop loss for the stock is Rs 1,470.
Out of 12 analysts tracking the company, eight maintain a 'buy' rating, three recommend a 'hold', and one suggests 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 10.6%.
Metropolis Healthcare
Metropolis Healthcare Ltd. got a buy recommendation from Rambhia. The target price for the stock is Rs 1,800 apiece, which implies a 5.3% upside from Tuesday's close price. The stop loss is at Rs 1,690 apiece.
Out of 24 analysts tracking the company, 18 maintain a 'buy' rating, two recommend a 'hold', and four suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 12.5%.
Tata Chemicals
Krishnan suggested a buy for Tata Chemicals Ltd. with a target price of Rs 940, which implied a 3.5% upside from Tuesday's close price. The stop loss is at Rs 875 apiece.
Out of eight analysts tracking the company, one recommends a 'hold', and seven suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies a downside of 17.3%.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
